This report entails a detailed quantitative analysis of the current and future trends from 2014 to 2022, which helps to identify the prevailing market opportunities.The market scenario is comprehensively analyzed with respect to the product type, applications, end users, and geography to assist in strategic business planning.
Portland, OR -- (SBWIRE) -- 06/13/2018 -- The Global 3D Cell Culture Market was valued at $765 million in 2015 and is projected to reach $4,691 million by 2022, growing at a CAGR of 29.4% from 2016 to 2022. Cancer research segment held nearly one-third of the total market in 2015.
View Detail Summary of this report: https://www.alliedmarketresearch.com/3d-cell-cultures-market
A 3D cell culture is an in vitro technique where cells can grow in an artificially created environment, which closely resemble the structure and functioning of the native tissues, thus stimulating normal differentiation, morphology, and behavior of cells. The growth of 3D cell culture market is driven by the technological advancements such as the development of improved scaffold-based & scaffold-free products, increase in research-related activities, and rise in demand for organ transplantations. The collaborations between companies, hospitals, and academic institutions have led to launch of new products, which further boost the market growth. In addition, stringent regulations against these of animal models for various pharmaceutical and diagnostic tests fuel the growth of the market. However, lack of skilled professionals and budget restrictions for research-related activities restrain the market growth.
Cancer research is anticipated to dominate the global 3D cell culture market throughout the analysis period. This is because the behavior of the cancer cells grown in 3D culture is similar to the cells that grow in vivo. Thus, 3D cell culture allows researchers to study various tumor characteristics such as hypoxia, dormancy, and anti-apoptotic behavior. The R&D activities in oncology have rapidly increased, owing to the multiple advantages of 3D cell culture.
Download free Sample report at : https://www.alliedmarketresearch.com/request-sample/1474
North America dominated the 3D cell culture market, governing around two-fifths of the global market value in 2015, and is expected to continue this trend throughout the forecast period. Advancements in various healthcare applications such as cancer and tissue engineering fuel the market growth. For instance, in 2016, a Canadian scientist created a miniature lattice structure called AngioChip that is anticipated to be used to grow human tissues outside the body. This person-on-a-chip technology is used to test the effects of drugs on human tissues.
Asia-Pacific possesses a high market potential for the 3D cell culture market owing to rise in demand for drug discovery and increase in focus on the biotechnology industry. Moreover, low operating costs of industries & laboratory setups and rise in government investments in healthcare due to increased risk of diseases such as cancer boost the market growth. Various government organizations and private companies, and pharmaceutical and analytical instrumental companies have largely invested in the 3D cell culture projects to meet the demand of the novel drug discoveries and organs development.
The 3D cell culture market in the Republic of South Africa is projected to grow at a CAGR of 28.4% during the forecast period. Increase in the focus of the key players on the emerging markets such as Asia-Pacific and LAMEA contributes toward the growth of the market. This is attributed to the low investments required to set up and operate an industry in these regions.
Do Purchase Report : https://www.alliedmarketresearch.com/purchase-enquiry/1474